Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Shteinberg

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Clinics in Chest Medicine|March 3, 2022
Diagnosis and Evaluation of BronchiectasisRaya Cohen, Michal Shteinberg
The European Respiratory Journal|February 22, 2024
Unravelling the "frequent exacerbator" phenotype in cystic fibrosisRaya Cohen, Michal Shteinberg
Seminars in Respiratory and Critical Care Medicine|July 14, 2021
Bronchiectasis Exacerbations: Definitions, Causes, and Acute ManagementSivan Perl, Michal Shteinberg
American Journal of Respiratory and Critical Care Medicine|September 25, 2025
Noncoding DNA Variants in Primary Ciliary Dyskinesia: Another Piece of the Diagnostic PuzzleMichal Shteinberg, Adam J Shapiro
Advances in Therapy|January 27, 2015
Use of inhaled tobramycin in cystic fibrosisMichal Shteinberg, J Stuart Elborn
Chest|February 12, 2025
Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use in Pregnancy: Is There Enough Evidence to Tip the Scale?Liora Boehm-Cohen, Michal Shteinberg
American Journal of Respiratory and Critical Care Medicine|March 25, 2025
Water, Water, Everywhere, Nor Any Drop to Drink - Beware of MycobacteriaTavs Qvist, Andrew Bush, Michal Shteinberg
Harefuah|August 19, 2015
[CYSTIC FIBROSIS SURVIVAL TRENDS IN CARMEL MEDICAL CENTER]Keren Nathan, Michal Shteinberg, Joseph Rivlin
European Respiratory Review : an Official Journal of the European Respiratory Society|March 22, 2020
Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung diseaseMichal Shteinberg, Jennifer L Taylor-Cousar
European Journal of Internal Medicine|January 16, 2007
Desensitization therapy in a patient with furosemide allergyMichal Shteinberg, Basheer Karkabi, Shai Cohen
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Clinics in Chest Medicine|March 3, 2022
Diagnosis and Evaluation of BronchiectasisRaya Cohen, Michal Shteinberg
The European Respiratory Journal|February 22, 2024
Unravelling the "frequent exacerbator" phenotype in cystic fibrosisRaya Cohen, Michal Shteinberg
Seminars in Respiratory and Critical Care Medicine|July 14, 2021
Bronchiectasis Exacerbations: Definitions, Causes, and Acute ManagementSivan Perl, Michal Shteinberg
American Journal of Respiratory and Critical Care Medicine|September 25, 2025
Noncoding DNA Variants in Primary Ciliary Dyskinesia: Another Piece of the Diagnostic PuzzleMichal Shteinberg, Adam J Shapiro
Advances in Therapy|January 27, 2015
Use of inhaled tobramycin in cystic fibrosisMichal Shteinberg, J Stuart Elborn
Chest|February 12, 2025
Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use in Pregnancy: Is There Enough Evidence to Tip the Scale?Liora Boehm-Cohen, Michal Shteinberg
American Journal of Respiratory and Critical Care Medicine|March 25, 2025
Water, Water, Everywhere, Nor Any Drop to Drink - Beware of MycobacteriaTavs Qvist, Andrew Bush, Michal Shteinberg
Harefuah|August 19, 2015
[CYSTIC FIBROSIS SURVIVAL TRENDS IN CARMEL MEDICAL CENTER]Keren Nathan, Michal Shteinberg, Joseph Rivlin
European Respiratory Review : an Official Journal of the European Respiratory Society|March 22, 2020
Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung diseaseMichal Shteinberg, Jennifer L Taylor-Cousar
European Journal of Internal Medicine|January 16, 2007
Desensitization therapy in a patient with furosemide allergyMichal Shteinberg, Basheer Karkabi, Shai Cohen
Pageof 15